TITLE

Chronic pancreatitis and cystic fibrosis

AUTHOR(S)
Witt, H.
PUB. DATE
May 2003
SOURCE
Gut;May2003 Supplement 2, Vol. 52, pIi31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recent discoveries of trypsinogen and trypsin inhibitor mutations in patients with chronic pancreatitis (CP) support the hypothesis that an inappropriate activation of pancreatic zymogens to active enzymes within the pancreatic parenchyma starts the inflammatory process. Current data suggest that CP may be inherited dominant, recessive, or complex as a result of mutations in the above mentioned or yet unidentified genes. Evaluation of patients with CP should include genetic testing. Cystic fibrosis (CF) is an autosomal recessive inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene and is characterized by pancreatic insufficiency and chronic bronchopulmonary infection. The progression and severity of pulmonary disease differs considerably between people with identical CFTR mutations and does not seem to correlate with the type or class of the CFTR mutation. The identification of further disease modifying genetic factors will increase the pathophysiological understanding and may help to identify new therapeutic targets.
ACCESSION #
10074563

 

Related Articles

  • Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis. Bo‰lle, Pierre-Yves; Viviani, Laura; Busson, Pierre-Francois; Olesen, Hanne V.; Ravilly, Sophie; Stern, Martin; Assael, Baroukh M.; Barreto, Celeste; Drevinek, Pavel; Thomas, Muriel; Krivec, Uros; Mei-Zahav, Meir; Vibert, Jean-Fran‡ois; Clement, Annick; Mehta, Anil; Corvol, Harriet // Orphanet Journal of Rare Diseases;2012, Vol. 7 Issue 1, p64 

    Background: The clinical course of Cystic Fibrosis (CF) is usually measured using the percent predicted FEV1 and BMI Z-score referenced against a healthy population, since achieving normality is the ultimate goal of CF care. Referencing against age and sex matched CF peers may provide valuable...

  • Genetic risk factors in chronic pancreatitisNielsTeichJohannOckengaVolkerKeimJoachimMössnerMed... Teich, Niels; Ockenga, Johan; Keim, Volker; M ö ssner, Joachim // Journal of Gastroenterology;2002, Vol. 37 Issue 1, p1 

    Provides information on a study which examined genetic risk factors in chronic pancreatitis. Mutations of the cationic trypsinogen gene and hereditary pancreatitis; Mutations of cystic fibrosis gene and idiopathic chronic pancreatitis; Conclusion.

  • CYSTIC FIBROSIS OF THE PANCREAS: CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Di Sant'Agnese, Paul A.; Jones, William O.; Dische, Zacharias // Annals of Internal Medicine;Mar61, Vol. 54 Issue 3, p482 

    Reports on two cases of cystic fibrosis of the pancreas, one a child and one an adult. Features of the disease; Description of some metabolic studies that lead to important considerations; Clinical investigations that point to an altered mucopolysaccharide metabolism as the possible basic...

  • CYSTIC FIBROSIS. Barbero, Giulio J. // Annals of Internal Medicine;Mar61, Vol. 54 Issue 3, p586 

    Editorial. Comments on the problem of cystic fibrosis of the pancreas. Diagnosis and pathogenesis; Physiology of sweating; Nature of the exocrine secretory process.

  • EVIDENCE OF CFTR DYSFUNCTION IN CHILDREN WITH RECURRENT PANCREATITIS.  // Archives of Disease in Childhood;Apr2003 Supplement, Vol. 88, pA15 

    Presents an abstract of the study 'Evidence of CFTR Dysfunction in Children With Recurrent Pancreatitis,' by M. Corpino, M.A. Thompson, P.J. Milla, A. Jaffe and K.J. Lindley, presented at the 7th Spring Meeting of the Royal College of Paediatrics and Child Health.

  • Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. McClaren, Belinda J.; Metcalfe, Sylvia A.; Aitken, MaryAnne; Massie, R. John; Ukoumunne, Obioha C.; Amor, David J. // European Journal of Human Genetics;Oct2010, Vol. 18 Issue 10, p1084 

    Newborn screening (NBS) for cystic fibrosis (CF) provides the opportunity for cascade carrier testing of relatives. Uptake of testing by adult non-parent relatives of children diagnosed with CF through NBS has not been previously described, and this study describes uptake by both parents and...

  • Notable contribution of large CFTR gene rearrangements to the diagnosis of cystic fibrosis in fetuses with bowel anomalies. de Becdelièvre, Alix; Costa, Catherine; LeFloch, Annick; Legendre, Marie; Jouannic, Jean-Marie; Vigneron, Jacqueline; Bresson, Jean-Luc; Gobin, Stéphanie; Martin, Josiane; Goossens, Michel; Girodon, Emmanuelle // European Journal of Human Genetics;Oct2010, Vol. 18 Issue 10, p1166 

    Grade III fetal bowel hyperechogenicity and/or loop dilatation observed at the second trimester of pregnancy can be due to several disease conditions, including cystic fibrosis (CF). Screening for frequent CF mutations is performed as a first step and, in certain situations, such as when a...

  • A NEW DAWN FOR THE TREATMENT OF CYSTIC FIBROSIS. Doherty, Peter; Downey, D. G. // Ulster Medical Journal;Sep2015, Vol. 84 Issue 3, p218 

    The article discusses the use of Ivacaftor (Kalydeco) in the treatment of patients with cystic fibrosis (CF), which targets the CF Transmembrane Conductance Regulator (CFTR) gene causing altered chloride and water transport.

  • Correction: Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis. Malats, Núria; Real, Francisco X. // New England Journal of Medicine;05/20/99, Vol. 340 Issue 20, p1592 

    A letter to the editor is presented in response to the article "Mutations of the cystic fibrosis gene in patients with chronic pancreatitis," by N. Sharer, seen in the September 3, 1999 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics